Same Indication

Nivolumab vs Warfarin

Nivolumab vs Warfarin: Overview

This comparison examines the pharmacological differences between Nivolumab and Warfarin.

Mechanism of Action

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Warfarin: Inhibits vitamin K epoxide reductase complex.

Pharmacokinetics

Half-life: Nivolumab β€” 27 days; Warfarin β€” 20-60 hours.

Chemical Properties

Molecular Formula: Warfarin β€” C19H16O4.

Molecular Weight: Warfarin β€” 308.3280 g/mol.

Type: Nivolumab β€” Antibody; Warfarin β€” Small molecule.